The Joint (The Joint) ROCE % : 10.97% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is The Joint ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. The Joint's annualized ROCE % for the quarter that ended in Mar. 2024 was 10.97%.

The Joint ROCE % Historical Data

The historical data trend for The Joint's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Joint ROCE % Chart

The Joint Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

16.30

14.03

10.89

1.82

0.90

The Joint Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-3.28	-1.25	0.04	8.80	10.97

The Joint ROCE % Calculation

The Joint's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	0.56	/	( ( (93.49 - 23.217)	+	(87.151 - 33.574) )	/ 2 )
	=	0.56	/	( (70.273	+	53.577)	/ 2 )
	=	0.56	/	61.925
	=	0.90 %

The Joint's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	5.808	/	( ( (87.151 - 33.574)	+	(85.684 - 33.347) )	/ 2 )
	=	5.808	/	( ( 53.577	+	52.337 )	/ 2 )
	=	5.808	/	52.957
	=	10.97 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

The Joint (NAS:JYNT) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

The Joint ROCE % Related Terms

Thank you for viewing the detailed overview of The Joint's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

The Joint (The Joint) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » The Joint Corp (NAS:JYNT) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

16767 North Perimeter Drive, Suite 110, Scottsdale, AZ, USA, 85260

Website

https://www.thejoint.com

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sale of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

Executives

Bandera Partners Llc	10 percent owner	50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Peter D Holt	officer: Chief Operating Officer	16767 N. PERIMETER DR., SUITE 240, SCOTTSDALE AZ 85260
Jake Singleton	officer: Chief Financial Officer	16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Ronald V Davella	director	2600 E SOUTHLAKE BLVD., STE 120-359, SOUTHLAKE TX 76092
Glenn J Krevlin	10 percent owner	600 FIFTH AVE, 11TH FL, NEW YORK NY 10020
Matthew E Rubel	director	3231 SE SIXTH AVENUE, TOPEKA KS 66607
Gregory Bylinsky	10 percent owner	C/O BANDERA PARTNERS LLC, 50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Jefferson Gramm	10 percent owner	C/O BANDERA PARTNERS LLC, 50 BROAD STREET, SUITE 1820, NEW YORK NY 10004
Amos James H. Jr	director	16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
John P Meloun	officer: Chief Financial Officer	16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
Abe Hong	director	16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Glenhill Advisors Llc	10 percent owner	600 FIFTH AVE, 11TH FL, NEW YORK NY 10020
Suzanne M Decker	director	16767 NORTH PERIMETER DRIVE, SUITE 240, SCOTTSDALE AZ 85260
Bret Sanders	director	16767 N. PERIMETER DR., STE. 240, SCOTTSDALE AZ 85260
David M Orwasher	officer: President and COO	242 W 36TH ST, NEW YORK NY 10018